1. Home
  2. PCRX vs TRIP Comparison

PCRX vs TRIP Comparison

Compare PCRX & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

BUY

Current Price

$36.35

Market Cap

1.0B

Sector

Health Care

ML Signal

BUY

Logo TripAdvisor Inc.

TRIP

TripAdvisor Inc.

HOLD

Current Price

$9.27

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
TRIP
Founded
2006
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
PCRX
TRIP
Price
$36.35
$9.27
Analyst Decision
Hold
Hold
Analyst Count
9
16
Target Price
★ $33.57
$13.36
AVG Volume (30 Days)
2.1M
★ 3.4M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
★ 675.00
EPS
★ 0.19
N/A
Revenue
$541,533,000.00
★ $1,556,000,000.00
Revenue This Year
$3.84
N/A
Revenue Next Year
$4.73
$3.35
P/E Ratio
$191.29
★ N/A
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$8.02
52 Week High
$36.67
$17.82

Technical Indicators

Market Signals
Indicator
PCRX
TRIP
Relative Strength Index (RSI) 83.97 54.14
Support Level $21.78 $9.03
Resistance Level N/A $11.76
Average True Range (ATR) 0.40 0.31
MACD 0.89 0.16
Stochastic Oscillator 97.44 73.11

Price Performance

Historical Comparison
PCRX
TRIP

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About TRIP TripAdvisor Inc.

Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, experiences, airlines, and cruises. In 2025, 42% of revenue came from the company's core Hotel and Other segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of revenue in 2025. The company is selling TheFork, its dining brand, which represented 12% of sales.

Share on Social Networks: